<SEC-DOCUMENT>0001387131-21-005159-index.html : 20210430 <SEC-HEADER>0001387131-21-005159.hdr.sgml : 20210430 <ACCEPTANCE-DATETIME>20210430165040 ACCESSION NUMBER: 0001387131-21-005159 CONFORMED SUBMISSION TYPE: 10-K/A PUBLIC DOCUMENT COUNT: 5 CONFORMED PERIOD OF REPORT: 20201231 FILED AS OF DATE: 20210430 DATE AS OF CHANGE: 20210430 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Adamis Pharmaceuticals Corp CENTRAL INDEX KEY: 0000887247 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 820429727 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-36242 FILM NUMBER: 21879099 BUSINESS ADDRESS: STREET 1: 11682 EL CAMINO REAL STREET 2: SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: (858) 997-2400 MAIL ADDRESS: STREET 1: 11682 EL CAMINO REAL STREET 2: SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: CELLEGY PHARMACEUTICALS INC DATE OF NAME CHANGE: 19950615 </SEC-HEADER> <DOCUMENT> <TYPE>10-K/A <SEQUENCE>1 <FILENAME>admp-10ka_123120.htm <DESCRIPTION>AMENDED 10-K <TEXT> Document 1 - file: admp-10ka_123120.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-31.1 <SEQUENCE>2 <FILENAME>ex31-1.htm <DESCRIPTION>CERTIFICATION BY CEO PURSUANT TO SECTION 302 <TEXT> Document 2 - file: ex31-1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-31.2 <SEQUENCE>3 <FILENAME>ex31-2.htm <DESCRIPTION>CERTIFICATION BY CFO PURSUANT TO SECTION 302 <TEXT> Document 3 - file: ex31-2.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-32.1 <SEQUENCE>4 <FILENAME>ex32-1.htm <DESCRIPTION>CERTIFICATION BY CEO PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 <TEXT> Document 4 - file: ex32-1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-32.2 <SEQUENCE>5 <FILENAME>ex32-2.htm <DESCRIPTION>CERTIFICATION BY CFO PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 <TEXT> Document 5 - file: ex32-2.htm
</DOCUMENT> </SEC-DOCUMENT>